Prospect

Today on TAP: Exhibit A is the case of the EpiPen. It should cost a few dollars rather than the $600 or more charged by monopolist Viatris.

Extreme inequality is bad for billionaires and ordinary citizens alike.

The Department of Labor plans to reverse the neoliberal-era gutting of a law that stopped contractors from bidding down wages in federal procurement.

Bidenomics has begun to de-financialize the economy.

As Brian Fallon leaves Demand Justice, one of several groups highlighting the urgency of the courts, the movement he helped lead has made real gains.

Today on TAP: The sly myopia of David Brooks

In a newly unsealed deposition, a former Express Scripts executive (unintentionally) reveals how hard his colleagues were undermining his ‘mission’ to cut drug prices.

The wave of professionals who are joining unions has now reached the ranks of physicians.

The credit card industry is attempting to whip up right-wing hysterics to fight a bipartisan financial reform.

Let’s make this trade.

Today on TAP: He’s too deluded to know he lost! Coups that fail don’t count! And other cornucopias of crap!

How orphan drugs became big business for Big Pharma

Jack Smith is doing the attorney general’s job for him, 28 months after it should have been done.

The trucking company’s demise reads like a history of modern capitalism.

An independent report casts doubt on the credibility of a major gas certification company.

Today on TAP: Jack Smith’s prosecution for conspiracy has led to a familiar blowback defense: prosecute the powerful and everyone will get hurt.

What to make of the recent news about alleged aliens?

These overdue charges take us only partway back to functioning democracy.

Dollar General is part of a trend of major retailers trying to move into medical care. Cut-rate treatment is the last thing needed in the vulnerable populations dollar stores serve.

How decades of policy failures led to the ever-powerful UnitedHealth Group